EU's CHMP recommends fifth H1N1 vaccine and intravenous Relenza
23 February 2010
Katie McQue
Please Login to read the full article.
23 February 2010
Katie McQue
katie.mcque@informa.com
The EU's CHMP has backed the conditional approval of Sanofi-Pasteur's adjuvanted H1N1 influenza vaccine Humenza for the prophylaxis of influenza in an officially declared pandemic situation.
This is the fifth H1N1 vaccine to be recommended by the CHMP. It follows the three vaccines that...
Please Login to read the full article.
RELATED CONTENT
NEWS
- CHMP says yes to Esmya for uterine fibroids symptoms and Vepacel pre-pandemic flu vaccine
- Flu prevention setback for Inavir: Biota blames high Japanese hygiene standards
- Cochrane group: Roche's refusal of access to Tamiflu data leaves questions unanswered
- US Capitol Capsule: With wish granted, Collins forges ahead with new translational science centre
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
